---
trial_id: 887
discovery_date: 2022-06-09 18:59:44.465087
date: 2022-06-09 18:59:44.465087
title: "A Phase III, Multi-center, Open-label, Randomized Study of Oral Asciminib Versus Investigator Selected TKI in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase"
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct04971226'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
